Unichem Laboratories Ltd
Company Profile
Business description
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
Contact
Off. S. V. Road
Unichem Bhavan, Prabhat Estate
Jogeshwari (West)
MumbaiMH400 102
INDT: +91 2266888333
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
2,153
Stocks News & Analysis
stocks
Unconventional wisdom: A controversial income pick
stocks
How to avoid dividend disaster
stocks
Why ASX miners will handily beat banks in the long-term
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,788.70 | 3.60 | 0.04% |
| CAC 40 | 8,007.62 | 115.94 | 1.47% |
| DAX 40 | 21,902.42 | 316.49 | 1.47% |
| Dow JONES (US) | 44,747.63 | 125.65 | -0.28% |
| FTSE 100 | 8,727.28 | 103.99 | 1.21% |
| HKSE | 21,067.52 | 175.90 | 0.84% |
| NASDAQ | 19,791.99 | 99.66 | 0.51% |
| Nikkei 225 | 38,893.65 | 172.88 | -0.44% |
| NZX 50 Index | 12,887.02 | 42.43 | 0.33% |
| S&P 500 | 6,083.57 | 22.09 | 0.36% |
| S&P/ASX 200 | 8,520.30 | 0.40 | -0.00% |
| SSE Composite Index | 3,296.59 | 25.93 | 0.79% |